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The complete DNA sequence of the Smith strain of murine cytomegalovirus (MCMV) was determined from
virion DNA by using a whole-genome shotgun approach. The genome has an overall G1C content of 58.7%,
consists of 230,278 bp, and is arranged as a single unique sequence with short (31-bp) terminal direct repeats
and several short internal repeats. Significant similarity to the genome of the sequenced human cytomegalo-
virus (HCMV) strain AD169 is evident, particularly for 78 open reading frames encoded by the central part of
the genome. There is a very similar distribution of G1C content across the two genomes. Sequences toward the
ends of the MCMV genome encode tandem arrays of homologous glycoproteins (gps) arranged as two gene
families. The left end encodes 15 gps that represent one family, and the right end encodes a different family of
11 gps. A homolog (m144) of cellular major histocompatibility complex (MHC) class I genes is located at the
end of the genome opposite the HCMV MHC class I homolog (UL18). G protein-coupled receptor (GCR)
homologs (M33 and M78) occur in positions congruent with two (UL33 and UL78) of the four putative HCMV
GCR homologs. Counterparts of all of the known enzyme homologs in HCMV are present in the MCMV
genome, including the phosphotransferase gene (M97), whose product phosphorylates ganciclovir in HCMV-
infected cells, and the assembly protein (M80).
A more complete understanding of the protein coding in
many herpesviruses has been assisted by the availability of the
complete DNA sequences of their genomes (2, 6, 22, 37, 38, 51,
94, 107a, 140, 141). Although previous analyses of the com-
plete nucleotide sequences of several herpesviruses have
largely confirmed their biological classification, there have
been notable exceptions, including human herpesvirus 6
(HHV-6) (51, 75), channel catfish virus (CCV) (37), herpesvi-
rus of turkeys, and Marek’s disease virus (16). Analysis of short
regions of the murine cytomegalovirus (MCMV) genome has
confirmed its biological classification as a betaherpesvirus. A
number of MCMV genes with counterparts in human cytomeg-
alovirus (HCMV) have been described, although the precise
location and order of the genes have not been determined (17,
31, 44, 70, 87, 91, 97, 98, 119, 154).
MCMV is a betaherpesvirus that causes acute, latent, and
persistent infection of the natural host (57, 115, 121). It has
been distinguished from other murine viruses on the basis of
cytopathic effect, tissue tropism, and morphology (111). Both
MCMV and HCMV have a highly restricted host range. As a
consequence of the difficulties associated with studies of
HCMV pathogenesis in humans, infection of mice with
MCMV has been used as a model for HCMV infection. The
major reason for using MCMV as a model is the matching
biological characteristics of these virus infections in their nat-
ural settings. Both MCMV and HCMV cause severe infections
in the immunocompromised or immunologically immature
host, resulting in similar clinical syndromes (28, 104, 111, 128).
In addition, both HCMV and MCMV are susceptible to the
antiviral agent 9-(1,3-dihydroxy-2-propoxymethyl)guanine
(DHPG, ganciclovir, or GCV) (127). However, MCMV and
HCMV have some biological differences, as transplacental
transmission of MCMV has not been demonstrated and mouse
models of fetal infection involve direct inoculation of MCMV
into the central nervous system or uterus (66, 144).
The genome of MCMV is known to comprise a single
unique sequence (type F) with short direct repeats (DRs) at
either end (43). The genome has a relatively high G1C content
(59%), like HCMV, herpes simplex virus (HSV), and Epstein-
Barr virus (EBV) but unlike varicella-zoster virus (VZV), hu-
man herpesvirus 6 (HHV-6), and herpesvirus saimiri (HVS).
An analysis of the complete 230-kb DNA sequence of the
Smith strain of MCMV is presented here. The genome is
predicted to contain 170 genes and was found to be essentially
colinear with the HCMV genome over the central 180 kb.
Counterparts of the G protein-coupled receptors (GCR),
UL25, UL82, and US22 gene families of HCMV were identi-
fied. There are 24- and 27-kb regions at the left and right ends
of the genome, respectively, that encode genes currently only
found in MCMV. Within these regions, families of tandemly
arranged genes are predicted to encode membrane glycopro-
teins, a feature that resembles the RL11 and US6 families
identified in HCMV. There are three open reading frames
(ORFs) with homology to eukaryotic cellular genes. The M33
and M78 ORFs have sequence similarity to GCRs, and the
predicted protein product of m144 is similar to major histo-
compatibility complex (MHC) class I proteins. Unlike the
MCMV GCR homologs which resemble the HCMV counter-
parts, the m144 ORF does not share amino acid sequence
similarity or colinearity with the HCMVMHC class I homolog
(UL18). A discussion of the proteins predicted to be encoded
by the ORFs defined in this analysis is presented.
MATERIALS AND METHODS
This study used a whole-virus-genome shotgun approach to determine the
DNA sequence (36), that is, sequencing templates were made directly from
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purified virion DNA, without the use of restriction fragment libraries. Regions of
ambiguity were then resolved by directed techniques (32).
Virus culture and template DNA preparation. The Smith strain of MCMV
(ATCC VR-194) was grown in mouse embryonic fibroblasts until the cultures
exhibited 90% cytopathic effect. Virions were purified from the culture super-
natant by two rounds of sucrose density gradient centrifugation. The virus was
pelleted and DNA was extracted with phenol-chloroform (8). The random clon-
ing and sequencing of whole virion DNA were performed by methods previously
described for sequencing of restriction fragments (7). Random fragments of
virion DNA of approximately 2 kb were generated by sonication, end repaired
with Klenow fragment of DNA polymerase to produce blunt ends, and used to
construct an M13 library (8). Single-stranded sequencing templates were pre-
pared using Escherichia coli TG1, by either previously described techniques (8)
or a modified method in microtiter trays (130) employing sodium iodide as the
chaotropic agent instead of sodium dodecyl sulfate for cell lysis (3). Double-
stranded DNA templates were generated by PCR from the M13 single-stranded
template with M13 forward and reverse PCR primers. To obtain sequence from
areas underrepresented in the M13 library, double-stranded DNA templates
were prepared by PCR of virion DNA. In several instances, custom oligonucle-
otide primers were used to generate sequence from single-stranded M13 tem-
plates containing inserts larger than 2 kb. Double-stranded templates were pu-
rified by precipitation with polyethylene glycol (32).
DNA sequencing. All sequences were obtained by modified dideoxy chain
termination techniques (125). The majority of sequences (85%) were determined
with an on-line fluorescent sequencing machine from Applied Biosystems (the
373A DNA sequencer), with version 2.0 of the analysis software. Dye-labelled
primers and Taq cycle-sequencing reactions were used to generate fluorescent
sequence data from templates (32). Sequence information from templates was
also obtained by standard radioactive sequencing techniques (8), and the data
from the autoradiographs were read with an Amersham film scanner and Base-
Scanner software versions 2.0 to 2.3. Data were generated from regions con-
taining compressions or single-stranded sequences by using double-stranded
templates, custom oligonucleotide primers, and Taq cycle sequencing with flu-
orescence-labelled dideoxynucleotides (59). The final sequence was well deter-
mined (39) on both strands over 99.19% of the genome, and each base was
represented in gel readings an average of 10.6 times.
Sequence assembly and screening of gel readings. Sequence data were com-
piled by using the program BAP (39, 134), and the sequences were edited on a
SUNMicrosystems computer. The output from all gel readings was standardized
to allow trace files of sequence data derived from autoradiographs and those
from the fluorescence-based sequencer to be assembled and handled in an
identical manner (40, 134). All gel readings were screened against files contain-
ing the sequences of M13mp18, a 5-kb LINE1 murine repeat sequence, and the
300-bp murine alu equivalent (SINE b1) sequence (60, 147). This initial screen
allowed removal of M13 and some murine sequences, as the murine repeats may
constitute approximately 10% of the mouse genome.
Analysis of homologies, protein coding content, and motif searches.Homology
searches with the local alignment algorithm BLAST (64) and the global align-
ment algorithm FastA (81) were performed against a nonredundant combined
database containing the SwissProt28 (March 1994) and PIR 39 (1994) protein
libraries. Examination of the DNA sequence for transcription signals was per-
formed by using the search features of the computer programs acedb (42b) and
DIANA (56a). Nucleotide motif searches were performed against a subset of
motifs derived from the EMBL 38 nucleotide library (March 1994) (48). The
sequence was analyzed for tandem and inverted repeats by using the programs
xnip (134), repeatsearch (112a), and quicktandem, tandem, and inverted (42a).
The strategies used to identify genes of MCMV likely to be coding were based
on those used in the sequence analysis of other herpesviruses. The major criteria
for identifying a coding sequence were the presence of an ORF with a minimum
length of 300 bp and less than 60% overlap with adjacent ORFs. In the ORFs
m29, m29.1; m48.1, m48.2; m107, m108; m117, m117.1; m119.4, m119.5; m134,
m135; and m147, m148 (Table 1), the overlap was greater than 60%, as the ORFs
were of similar length, and none of the other ORF identification criteria distin-
guished between them satisfactorily. In addition, analysis of third-position bias,
the presence of consensus promoter and translation initiation sequences, and
similarity to known genes were used to support initial ORF selections. Gaps
between ORFs were inspected for smaller potential reading frames and were
included in the final coding map if they satisfied the other criteria used for ORF
selection. Multiple alignments were done by using the program clustal V (54), with
gap penalties of 10 (fixed) and 10 (floating), and the PAM250 protein weight matrix.
Nomenclature. The naming system used for genes of MCMV numbers them
from the left end of the prototype genome (69). As the MCMV and HCMV
genomes were found to be essentially colinear over the central parts of both
genomes, the numbering system for these MCMV genes is congruent with the
HCMV numbering system for the long unique (UL) region. MCMV genes with
homologs in HCMV are indicated by uppercase prefixes (M25), whereas ORFs
without sequence similarity with HCMV genes are indicated by lowercase pre-
fixes (m02). In order to maintain the correlation between the two numbering
systems, suffixes (as in m25.1 and m25.2, etc.) were introduced when additional
unique MCMV genes were found between homologs of HCMV genes. These
suffixes do not indicate any similarity between these genes. When MCMV genes
were found to be homologous with gene families of HCMV (and also with other
members of the gene families of MCMV and HCMV), this is indicated in Table
1. No attempt was made to correlate MCMV homologs with the numbering system
of the HCMV short unique (US) and repeat (TRL, IRL, IRS, and TRS) regions.
Nucleotide sequence accession number. The complete DNA sequence has
been submitted to the GenBank database, accession number U68299.
RESULTS
Features of the nucleotide sequence of MCMV. The genome
of MCMV Smith is 230,278 bp in length, which is around 5 kb
less than the size estimated from restriction fragment analysis
of the Smith strain (43). The overall G1C content is 58.7%,
with markedly reduced G1C content between 155 to 163 kb,
within HindIII fragment F (Fig. 1). The regions between 1 and
17 kb (HindIII fragment A) and 204 and 221 kb (HindIII
fragments O, P, and E) also show a less prominent reduction in
G1C content. These regions of reduced G1C content are
congruent with the positions of members of the MCMV mem-
brane glycoprotein families m02 and m145, respectively (Fig.
1), and are colinear with regions of reduced G1C content in
the HCMV genome. There is no evidence of generalized CpG
suppression. The arrangement of the CpG dinucleotides across
the genome shows localized CpG suppression corresponding
to the major immediate-early (MIE) region (Fig. 1), as was
found for HCMV (56).
The viral genome is a single long unique sequence, with
short (31-bp) DRs at either end (Fig. 2). These two DRs are
not represented elsewhere in the genome. The termini differ
from those published for strain K181 (89). The Smith termini
have one less C residue at position 34 (outside the left DR) and
one additional residue at position 1 (within the left DR) and
position 230,268 (within the right terminal DR). Other DRs
are clustered within the m02 membrane glycoprotein family at
the left end of the genome (within the regions covered by genes
m08, m11, and m12), within M83, within the A1T-rich region
between 154.5 and 162 kb, within M117, at the start of
M122(ie3), and in the m123(ie1) promoter (Fig. 2). The MIE
region has five 94-bp DRs between base 183312 and base
183778 (42). There are also short inverted repeat sequences
located throughout the genome (Fig. 2). They are present
upstream of m59, in the A1T-rich origin of replication region
between 154.5 and 162 kb (92), in M112, and in the m123(ie1)
promoter region (42).
Protein coding content. The arrangement of the MCMV
genes homologous with those of other herpesviruses is shown
in Fig. 3 as unfilled blocks and explained in the legend. All of
the conserved herpesvirus gene blocks are retained in MCMV,
and the position and orientation of these blocks are identical
with those in HCMV (22) and HHV-6 (51). It is predicted that
the genome encodes 170 ORFs, of which 78 have significant
amino acid identity with genes of HCMV (Table 2). These
homologs are located within the central part of the genome,
interspersed with a small number of ORFs predicted to encode
genes unique to MCMV. Homologs of the HCMV gene fam-
ilies UL25, UL82, and US22 and the GCRs are present, but
MCMV contains no amino acid sequence homologs of the
RL11, US1, US2, US6, or US12 gene families of HCMV. Not
present are MCMV homologs of the extra 19 ORFs described
for HCMV strain Toledo or the extra three ORFs found in
HCMV strain Towne, additional to those described for HCMV
strain AD169 (20). A number of HCMV genes with as yet
poorly understood functions are moderately to strongly con-
served and correspond to the MCMV genes M26, M27, M31,
M34, M47, M49, M50, M51, M71, M76, M87, M88, M91, M92,
M93, M94, M95, and M103.
The genome and individual ORFs. (i) Spliced genes.MCMV
genes that are known to be spliced in the Smith strain are
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TABLE 1. Summary of the map locations and features of the 170 predicted ORFs of the MCMV (strain Smith) genomea
ORF Strand
Positionb Length
(aa)
MW
(kDa)
HCMV
namec Comments (reference[s])
d
From: To:
m01 C 483 836 118 13.3
m02 999 1976 326 36.6 Glycoprotein family m02
m03 2236 3099 288 32.4 Glycoprotein family m02
m04 3270 4067 266 30.2 Glycoprotein family m02
m05 4185 5207 341 38.0 Glycoprotein family m02
m06 5300 6334 345 38.7 Glycoprotein family m02
m07 6463 7404 314 34.2 Glycoprotein family m02
m08 7459 8526 356 39.2 Glycoprotein family m02
m09 8632 9510 293 32.1 Glycoprotein family m02
m10 9624 10496 291 32.0 Glycoprotein family m02
m11 10715 11611 299 33.2 Glycoprotein family m02
m12 11686 12501 272 30.4 Glycoprotein family m02
m13 12599 12997 133 14.4 Glycoprotein family m02
m14 13085 13987 301 33.8 Glycoprotein family m02
m15 14085 15062 326 35.6 Glycoprotein family m02
m16 15044 15673 210 23.1 Glycoprotein family m02
m17 C 15752 16951 400 45.9 Member of MGP family m145 (right end)
m18 C 17074 20193 1040 108.5
m19 20338 20778 147 17.3
m20 C 20805 23045 747 82.5
m21˙ 22645 23331 229 25.3
m22 23586 23897 104 11.1
M23 C 23781 24953 391 43.1 UL23 (GF2) P US22 family homolog
m23.1 24826 25158 111 12.1
M24 C 25151 26119 323 35.8 UL24 (GF2) US22 family homolog
M25 26015 28810 932 103.2 UL25 (GF1) UL25 family homolog (34)
m25.1** C 29001 30281 427 47.5 UL23 (GF2) US22 family homolog
C 29001 30602 534 60.4 UL23 (GF2)
C 30248 31216 323 35.4 US22 (GF2)
m25.2** C 30248 31657 470 51.8 US22 (GF2) US22 family homolog
M26 C 31350 31925 192 21.7 UL26
M27 C 32250 34295 682 78.7 UL27
M28 C 34489 35778 430 47.3 UL28
m29˙ 35747 36727 327 35.7
m29.1˙ C 36112 36660 183 19.8
m30 36884 37726 281 30.8
M31 37279 38826 516 56.7 UL31
M32 C 39283 41436 718 78.6 UL32 (pp150) Tegument protein of HCMV (61, 62)
M33 41486 42777 377 42.2 UL33 (GCR) Spliced GCR (21, 35)
M34 43083 45644 854 94.5 UL34
M35 45909 47465 519 58.1 UL35 (GF1) UL25 family homolog
M36 C 47621 49267 507 56.9 UL36 (GF2) M36 E11E2, US22 family homolog (72)
M36 Ex2 C 47621 48909 429.7 48.2 UL36 Exon 2 US22 family homolog (72)
M36 Ex1** C 49036 49267 77.3 8.7 UL36 Exon 1 US22 family homolog (72)
M37 C 49444 50478 345 38.0 UL37 Glycoprotein present at IE times (72)
M38 C 50465 51955 497 54.8 UL38 (72)
m39 C 52487 53200 238 25.6
m40 C 53268 53630 121 13.3
m41 C 53786 54199 138 14.6
m42 C 54355 54843 163 17.7 Possible glycoprotein
M43 C 55354 57144 597 67.0 UL43 P US22 family homolog
M44 C 57888 59120 411 44.6 UL44 (DPAP) DNA binding protein (46)
M45e C 59518 62145 876 96.9 UL45 (RRL) Homolog of the large subunit of ribonucleotide reductase (117)
m45.1 C 61767 63038 424 42.0
M46 C 63043 63924 294 33.2 UL46 Minor capsid protein (114)
M47 63923 67042 1,040 118.1 UL47
M48 67042 73488 2,149 238.5 UL48 (Teg) Large tegument protein (131)
m48.1˙ 73562 73870 103 11.1
m48.2˙ C 73574 73867 98 9.8
M49 C 73922 75529 536 60.8 UL49
M50 C 75504 76451 316 34.7 UL50
M51** C 76518 77216 233 25.1 UL51
M52 76915 78465 517 59.2 UL52
M53 78461 79459 333 38.3 UL53
M54 C 79704 82994 1,097 123.8 UL54 (DNApol) DNA polymerase delta subtype (73)
M55 C 83006 85816 937 104.9 UL55 (gB) Glycoprotein B (29, 119)
M56 C 85719 88112 798 89.0 UL56 (NM) HSV ICP18.5 homolog (12, 51)
M57 C 88322 91894 1,191 131.4 UL57 (MDBP) Major DNA binding protein (4, 5)
m58 91761 92462 234 25.4
m59 93241 94260 340 35.5
Continued on following page
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TABLE 1—Continued
ORF Strand
Positionb Length
(aa)
MW
(kDa)
HCMV
namec Comments (reference[s])
d
From: To:
M69 C 96196 98721 842 93.0 UL69 Similar to HCMV transactivator (151)
m69.1˙ 98530 98886 119 12.7
M70 C 99013 101904 964 109.8 UL70 (HP) (34)
M71 101903 102799 299 32.9 UL71
M72 C 103034 104236 401 45.0 UL72 (dUTPase) (118)
M73 104100 104516 139 14.9 UL73
m74 C 104499 105812 438 49.1 UL74 P Possible glycoprotein
M75 C 106113 108287 725 81.3 UL75 (gH) Glycoprotein H (30, 154)
M76 108384 109145 254 28.9 UL76
M77 108931 110814 628 68.6 UL77 Pyruvoyl decarboxylase homolog (156)
M78 110989 112401 471 51.5 UL78 GCR homolog (51)
M79 C 112642 113415 258 29.4 UL79
M80 113414 115504 697 74.0 UL80 (AP) Assembly protein, protease (9, 84)
M82 C 115714 117507 598 67.4 UL82 (pp71) Upper matrix phosphoprotein (123)
M83 C 117617 120043 809 90.9 UL83 (pp65) Lower matrix phosphoprotein (123)
M84 C 120085 121845 587 64.5 UL84 Early nuclear nonstructural protein (53)
M85 C 122192 123124 311 34.6 UL85
M86 C 123202 127260 1,353 151.4 UL86 (MCP) Major capsid protein (23)
M87 127383 130160 926 102.4 UL87
M88 130243 131520 426 47.3 UL88
M89 Ex2 131649 132771 374.3 42.8 UL89 (CHS) Conserved herpesvirus spliced gene (27)
m90 C 132923 133876 318 35.8 Potential MGP
M91 133668 134069 134 14.1 UL91
M92 134075 134764 230 25.4 UL92
M93 134733 136277 515 58.1 UL93
M94 136234 137268 345 37.7 UL94
M89 Ex1 C 137393 138283 296.7 34.0 UL89 (CHS) Conserved herpesvirus spliced gene (27)
M95 138282 139532 417 45.8 UL95
M96 139535 139921 129 14.2 UL96
M97 140141 142069 643 71.1 UL97 (PK) Phosphotransferase, HCMV UL97 phosphorylates GCV (82, 139)
M98 142101 143783 561 62.0 UL98 (DNase) Exonuclease (96)
M99 143723 144058 112 11.9 UL99 (pp28) Phosphoprotein (100)
M100 C 144299 145411 371 42.3 UL100 (gM) Glycoprotein M or integral membrane protein (79, 126)
M102 145596 148031 812 91.0 UL102 (HP) Helicase-primase component (85, 129)
M103 C 148185 149135 317 35.4 UL103 (85)
M104 C 149116 151227 704 80.6 UL104 Structural protein (131)
M105 151028 153871 948 106.4 UL105 (Hel) DNA helicase (90)
m106 C 153916 154356 147 15.9
m107˙ 161983 162675 231 24.6
m108˙ C 162213 162770 186 19.8
M112 Ex1 163097 163889 264.3 27.7 UL112 Exon 1 of e1 (17); total e1 length is 330 aa, MW is 36.4 kDa
M113 163983 165076 364.7 38.3 UL113 P Potential alternative splice to M112 Ex1 (17), as found for
HCMV UL112/UL113 (153)
M112 Ex2 163983 164159 59 6.2 UL112 Exon 2 of e1 (17)
M112 Ex3 164486 164505 6.7 0.7 UL112 Exon 2 of e1 (17)
M114 C 165599 166384 262 29.6 UL114 (UNG) Uracil DNA glycosylase homolog (152)
M115 C 166387 167208 274 31.2 UL115 (gL) Glycoprotein L (67, 155)
M116 C 167208 169142 645 66.1 UL116 Serine-alanine-rich glycoprotein
m117˙ C 169216 170910 565 61.4
m117.1˙ 169541 170953 471 45.3
M118 C 170983 171633 217 24.8 UL118 Possible splice to m119 as for HCMV UL118 (77, 120)
m119 C 171646 171945 100 11.6 Conserved UL119 position
m119.1 C 172059 172991 311 35.2 Potential glycoprotein
m119.2 C 173025 173390 122 13.5
m119.3 C 173413 173721 103 10.8
m119.4˙ C 174057 174335 93 10.8
m119.5˙ 174154 174486 111 11.9
m120 C 174302 174574 91 10.1
M121 C 175682 177775 698 73.2 UL121 P Serine-alanine-rich glycoprotein with low homology to HSV-1 ICP0
M122 Ex5 C 177983 179517 511.7 UL122 (IE2) MCMV ie3, with mRNA terminating at base 177817 (98); total
length of Ex2 plus Ex3 plus and Ex5 is 611 aa, MW is 68.1 kDa
m123 Ex4 C 179763 181249 495.7 ie1 exon 4, with mRNA terminating at base 179544 (68–70); total
length of Ex2 plus Ex3 plus Ex4 is 595 aa, total MW is 66.7 kDa
m123 Ex3 C 181372 181562 63.7 ie1/ie3 exon 3
m123 Ex2 C 181660 181766 35.7 ie1/ie3 exon 2; initiating ATG for ie1/ie3 at nucleotides 181764 to
181766
m124 181933 182277 115 12.4
m124.1˙ C 182014 182418 135 15.1
m125 183436 183762 109 12.8
m126 184535 184807 91 10.4
Continued on following page
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M112-M113(e1) and the IE genes M122(ie3), m123(ie1), and
M128(ie2), as indicated in Fig. 3 and in Table 1. An alternative
splice donor for M112 predicted from sequence analysis is
shown in Table 3. The M112-M113 gene would potentially
encode a much longer carboxy tail if the donor represented in
Table 3 rather than the published M112 site were used (17).
The major protein translated from the e1 gene is approxi-
mately 36 kDa in size, although four proteins in the size range
33 to 38 kDa were recognized by immunoprecipitation of viral
proteins using murine monoclonal antibodies. If the alternative
TABLE 1—Continued
ORF Strand
Positionb Length
(aa)
MW
(kDa)
HCMV
namec Comments (reference[s])
d
From: To:
m127 C 185193 185591 133 14.9
m128 Ex3 186085 187296 404 45.5 US22 (GF2) ie2 exon 3, with mRNA terminating at base 187353 (98);
additional C residue at base 187166 compared to that in
reference 98
m129 C 187350 187847 166 18.8
m130˙ 187807 188277 157 17.5
m131˙ C 188029 188376 116 13.0
m132 Ex2 C 188382 188601 7 37.0 Exon 2 of M133(sgg1) (74, 87); total MW of Ex1 plus Ex2 shown
m133 Ex1 C 188881 189795 305 Exon 1 of M133(sgg1) (74, 87); alternative donor present in
Smith strain at position 188840
m134˙ 189868 190278 137 14.9
m135˙ C 189898 190221 108 11.6 39 coterminal with M133(sgg1) in MCMV strain K181 and shares
splice acceptor sequence with exon 2 (74)
m136 C 190313 191071 253 28.8
m137 C 191091 192092 334 37.1 Possible glycoprotein
m138 C 192236 193942 569 63.1 fcr1 Fc receptor glycoprotein (142)
m139 C 194085 196016 644 71.8 US22 (GF2) US22 family homolog
m140 C 196065 197516 484 55.8 US23 (GF2) US22 family homolog
m141 C 197708 199231 508 57.2 US24 (GF2) US22 family homolog
m142 C 199444 200748 435 49.0 US26 (GF2) US22 family homolog
m143 C 200923 202593 557 63.6 US23 (GF2) US22 family homolog
m144 C 202745 203893 383 42.7 MHC class I homolog (10, 14)
m145 C 204032 205492 487 54.6 Member of MGP family m145
m146 C 205645 206775 377 42.2 Member of MGP family m145
m147˙ C 206865 207299 145 16.9 Possible multiple membrane spanning protein
m148˙ 206928 207284 119 13.6
m149 207326 208012 229 25.6
m150 C 207626 208789 388 42.8 Member of MGP family m145
m151 C 208817 209983 387 42.4 Member of MGP family m145
m152 C 210244 211377 378 43.5 Member of MGP family m145
m153 C 211590 212804 405 45.5 Member of MGP family m145
m154 C 212945 214048 368 37.7 Threonine-serine-rich glycoprotein of MGP family m145, some
homology to EHV1 g(X) (141)
m155 C 214437 215567 377 42.8 Member of MGP family m145
m156 C 215537 215977 147 16.8
m157 C 215898 216884 329 37.1 Member of MGP family m145
m158 C 216935 218002 356 40.0 Member of MGP family m145
m159 C 218173 219366 398 44.1 Putative membrane glycoprotein
m160 C 219601 220524 308 34.3 Putative membrane glycoprotein
m161 C 220475 221149 225 25.5 Putative membrane glycoprotein
m162 C 221189 221665 159 16.7 Putative membrane glycoprotein anchor sequence only
m163 C 221878 222414 179 19.1 Putative membrane glycoprotein
m164 C 222369 223649 427 46.6 Putative membrane glycoprotein
m165 C 223283 224278 332 35.8 Putative membrane glycoprotein
m166 C 224416 225561 382 42.4 Putative membrane glycoprotein
m167 C 225782 227089 436 47.7 Putative membrane glycoprotein
m168 227920 228462 181 19.9
m169 C 228313 228708 132 15.3
m170 C 229342 230046 235 26.5
a Abbreviations and symbols: MW, molecular mass; Ex1, Ex2, and Ex3, exons 1, 2, and 3 of spliced genes; MGP, potential membrane glycoprotein; P, positional
homolog; ●, ORFs that overlap another gene for greater than 60% of their length, that have no homologs in herpesviruses or cellular proteins, and that are less likely
to be coding; pp, ORFs trimmed to a second methionine downstream of the 59 end, on the basis of alignment with HCMV, HHV-6, and/or overlap with adjacent ORFs;
gp, glycoproteins; GF2, members of the US22 gene family; GF1, members of the UL25 gene family; DPAP, DNA polymerase accessory protein; RRL, large subunit
of ribonucleotide reductase; DNApol, DNA-dependent DNA polymerase; NM, homolog of HSV ICP 18.5 involved in nucleocapsid maturation; HP, component of the
helicase-primase complex.
b “From” and “To” indicate the limits of the MCMV genes on the prototype genome arrangement. References are given to published data for the HCMV homolog
or the MCMV gene.
c HCMV homologs or alternative (descriptive) names for MCMV-specific ORFs.
d Known exon length where the exon length has been determined from transcription data and differs from the predicted ORF length.
e The ORF M45 has not been trimmed, as there is similarity between the MCMV and HCMV homologs extending upstream of the first methionine, which would
be consistent with splicing of this ORF in MCMV and HCMV.
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donor site present in M112 were used (see Table 3), a primary
translation product of around 66 kDa would be predicted.
Additional transcription data are required to decide which of
these two splice donor sites are used by the virus. The donor
and acceptor sites shown in Table 3 that have not been mapped
were predicted on the basis of homology with consensus her-
pesvirus splice sites. These include the MCMV ORFs down-
stream of m123(ie1) and M122(ie3). These ORFs are similar
to HCMV UL118, UL117, UL116, and UL115, which have
been shown to undergo differential splicing, resulting in 39
coterminal transcripts at IE and late times after infection (77,
120). Positional or amino acid sequence homologs of HCMV
UL115-119 were identified in MCMV, and there were pre-
dicted splice sites for the homologs of UL119/118 identified
(Table 3). Consensus splice sites were found within MCMV
M36 but not in M37. These ORFs are the homologs of known
spliced HCMV IE genes UL36 and UL37 (72). Predicted
splice sites within the MCMV homolog of the conserved late
spliced gene of herpesviruses (M89) are consistent with known
splicing occurring in the homologous gene of HCMV (120).
In the more virulent K181 strain of MCMV, the m133 (sgg1)
gene has been shown to be spliced (74, 87). The ORFs encod-
FIG. 1. The G1C content of the entire MCMV (Smith) genome is shown on the upper plot, with the horizontal line representing 50% G1C content. The cor-
responding CpG content is shown on the lower plot, with the lower horizontal line representing zero CpG content. The lowest horizontal scale is divided into 10-kbp seg-
ments. Both figures were generated with xnip software, with a window length of 20 (133). TheHindIII restriction fragments are shown in the central part of the figure (43).
FIG. 2. DR sequences within the MCMV genome (of more than 30 contiguous nucleotides) are joined by shorter curved or vertical lines. Inverted repeats are joined
by the taller curved lines.
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12 12 12
ing the Smith strain sgg1 gene (m133 and m132) lie on the
complementary strand near m128(ie2) (Fig. 3) between nucle-
otides 189795 and 188382. In the K181 strain, these encode a
major 1.5- and a minor 1.8-kb transcript at early times postin-
fection (87). Use of an additional splice donor site in Smith
strain (at nucleotide 188840) would produce a 392- rather than
a 312-residue protein. The published data for strain K181
suggest that this gene may encode proteins of 30 to 70 kDa in
size, and the longer putative protein here would be predicted
to be 44 kDa in size. Expression of the gene in cell culture
produces a 37-kDa product (74). Recent evidence has shown
that both HCMV UL33 and MCMV strain K181 M33 are
spliced at the 59 end, and the sequences at the splice sites are
shown in Table 3. MCMV (M33) utilizes consensus donor and
acceptor sequences located near the predicted amino terminus
of the gene (35). The HCMV homolog (UL33) has also been
shown to be spliced, and the HHV-6 homolog (U12 or P1RF1)
is predicted to be spliced at a similar position in the gene (35).
(ii) Proteins essential for origin-dependent replication.
MCMV homologs of six of the seven proteins necessary for
HSV-1 replication were identified, namely, the DNA polymer-
ase (M54), a polymerase accessory protein (M44), the single-
stranded DNA binding protein (M57), and the helicase-pri-
mase complex of three proteins (M70, M102, and M105). The
six motifs described in DNA helicases, including those of HSV
(157) and HCMV, are found in congruent positions in MCMV
M105(Helicase). Like EBV and HCMV, MCMV does not
encode a gene with sequence similarity to that of HSV-1 UL9
(origin binding protein). HHV-6 is known to encode an origin
binding protein (U73) and therefore differs from the other
sequenced betaherpesviruses in this respect (51). MCMV does
not possess a sequence or positional homolog of HCMV
UL101. At least part of UL101 lies within a region that en-
codes trans-acting factors that function in HCMV DNA repli-
cation in transient transfection assays (112). Five additional
loci (comprising nine ORFs) that are required for transient
complementation of the HCMV lytic origin of replication
(112) are present in MCMV, including homologs of HCMV
UL112/113 [M112/113(e1)] and UL84 (M84) (17, 53, 136).
HCMV UL84 is known to interact with UL122(IE2), possibly
FIG. 3. Map of MCMV (strain Smith) showing the ORFs on the top strand (coding left to right) above those on the bottom strand (coding right to left) from the
start (base 1) to the end (base 230278) of the prototype arrangement of the genome. MCMV predicted genes are numbered (as in Table 1) from m01 to m170, with
a suffix (such as 25.1) introduced to keep the MCMV and HCMV gene numbering systems congruent. Established HCMV homolog names are shown (131), and ORFs
encoding known or predicted exons are joined by lines. Shading is used to distinguish genes unique to MCMV from those with HCMV homologs (no shading unless
a member of a gene family). The gene families are shaded, with the m02 (_), M25 ( ), US22 homologs ( ), matrix proteins M82 and M83 ( ), and m145 (^) families
distinguished. Abbreviations for homologs and/or corresponding genes of HCMV (shown in brackets): AP, assembly protein (UL80); CHS, conserved herpesvirus
spliced gene (UL89); DNase, alkaline exonuclease (UL98); DNApol, DNA-dependent DNA polymerase (UL54); DPAP, DNA polymerase accessory protein (UL44);
dUTPase (UL72); GCR (UL33); gB (UL55); gH (UL75); gL (UL115); GF1, members of the UL25 gene family (UL25, UL35); GF2, members of the US22 gene family;
Hel, helicase-primase subunit containing conserved motifs (UL105); MHCI, MHC class I homolog (UL18); HP, component of the helicase-primase complex (UL70);
ie, spliced immediate-early glycoprotein (UL36); ie1, immediate-early gene 1 (UL123); ie2, immediate-early gene 2; ie3, immediate-early gene 3 (UL122); MCP, major
capsid protein (UL86); MDBP, major single-stranded DNA binding protein (UL57); NM, homolog of HSV ICP 18.5 involved in nucleocapsid maturation (UL56); PK,
phosphotransferase, protein kinase, or ganciclovir kinase (UL97); pp28, 28-kDa phosphoprotein (UL99); pp65, phosphoprotein 65 (UL83); pp71, phosphoprotein 71
(UL82); pp150, large structural phosphoprotein (UL32); RRL, large subunit of ribonucleotide reductase (UL45); UNG, uracil-DNA glycosylase (UL114).
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TABLE 2. Similarity between the 78 MCMV genes with amino acid sequence homology to HCMVa
MCMV
gene
Length
(aa)
HCMV
homolog:
Homolog
length (aa)
FastA identity for
overlap (%)
Overlap
length (aa)
FastA
scoreb
M23 391 UL23 (GF2) Pc 342 39 54 110
M24 323 UL24 (GF2) 358 23 282 214
M25 932 UL25 (GF1) 656 22 531 378
m25.1** 427 UL23 (GF2) 342 21 270 148
m25.2** 470 US22 (GF2) 358 20 337 104
M26 192 UL26 188 37 126 284
M27 682 UL27 608 23 416 392
M28 430 UL28 379 19 246 108
M31 516 UL31 694 24 313 191
M32 718 UL32 (pp150) 1,048 25 285 329
M33 377 UL33 (GCR) 390 47 324 924
M34 854 UL34 504 27 312 470
M35 519 UL35 (GF1) 640 24 499 490
M36 Ex2 429.7 UL36 Exon 2 408.7 25 302 262
M36 Ex1** 77.3 UL36 Exon 1 67.3
M37 345 UL37 487 20 284 162
M38 497 UL38 331 25 311 407
M43 597 UL43 P 187 25 61 95
M44 411 UL44 (DPAP) 433 59 351 1,035
M45 876 UL45 (RRL) 915 28 662 684
M46 294 UL46 290 39 268 600
M47 1,040 UL47 982 26 620 754
M48 2,149 UL48 (Teg) 2,241 22 1,595 1,216
M49 536 UL49 570 40 470 1,104
M50 316 UL50 397 46 252 610
M51** 233 UL51 157 55 78 278
M52 517 UL52 668 44 250 637
M53 333 UL53 376 49 280 788
M54 1,097 UL54 (DNApol) 1,242 50 415 1,202
M55 937 UL55 (gB) 906 44 550 1,220
M56 798 UL56 (NM) 850 42 696 1,373
M57 1,191 UL57 (MDBP) 1,235 51 597 1,717
M69 842 UL69 744 25 514 593
M70 964 UL70 (HP) 1,062 36 982 1,962
M71 299 UL71 411 41 201 492
M72 401 UL72 (dUTPase) 388 23 281 259
M73 139 UL73 138 34 95 195
M75 725 UL75 (gH) 743 23 693 783
M76 254 UL76 325 38 242 434
M77 628 UL77 642 49 478 1,191
M78 471 UL78 431 20 249 240
M79 258 UL79 295 49 246 728
M80 697 UL80 (AP) 708 30 736 478
M82 598 UL82 (pp71) 559 19 360 182
M83 809 UL83 (pp65) 561 17 323 192
M84 587 UL84 586 22 189 130
M85 311 UL85 306 55 313 931
M86 1,353 UL86 (MCP) 1,370 53 896 2,587
M87 926 UL87 941 59 408 1,266
M88 426 UL88 429 28 432 379
M89 Ex2 374 UL89 (CHS) 378 65 673 2,400
M91 134 UL91 111 39 65 147
M92 230 UL92 201 50 199 656
M93 515 UL93 594 33 89 196
M94 345 UL94 345 32 343 612
M89 Ex1 297 UL89 (CHS) 296
M95 417 UL95 531 59 108 386
M96 129 UL96 115 26 94 106
M97 643 UL97 (PK) 707 37 441 844
M98 561 UL98 (DNase) 584 51 144 439
M99 112 UL99 (pp28) 190 35 66 95
M100 371 UL100 (gM) 372 47 350 1,026
M102 812 UL102 (HP) 798 35 220 345
M103 317 UL103 249 33 252 494
M104 704 UL104 697 42 406 763
M105 948 UL105 (Hel) 956 43 861 1,955
M112 Ex1 264 UL112 252.3 34 274 389
Continued on following page
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mediating transcriptional control (132). The alkaline exonucle-
ase (DNase) gene (M98) that is required for HSV-1 growth in
cultured cells was highly conserved in MCMV (Table 2) (96).
There is a short (22-base) inverted repeat close to the start of
the MCMV gene, unlike with HCMV UL98 gene.
The MCMV origin of replication has been mapped in
MCMV strain K181 to a region corresponding to HindIII D of
MCMV strain Smith (92). The minimum sequence functioning
as the origin of replication in lytic infection has previously been
shown to be 1.5 kb in length and to contain 32-bp repeats (six
in strain K181 [92] and four in strain Smith sequenced here).
The origin is located upstream of the single-stranded DNA
binding protein (M57) within an A1T-rich region of the ge-
nome, lying approximately between nucleotides 93870 and
94500 (Fig. 1). This region in strain Smith contains two poten-
tial ORFs (m58 and m59), although they have no similarity to
known genes of other herpesviruses.
(iii) Other genes involved in DNA and nucleotide metabo-
lism. Homologs of enzymes found in other herpesviruses, which
are required for nucleotide metabolism, replication, and repair,
TABLE 3. Location and nucleotide sequences of the donor and acceptor sites of predicted MCMV homologs of HCMV
spliced ORFs and known MCMV ORFsa
MCMV
ORF
HCMV
homolog
Splice position MCMV sequence
Donor Acceptor Donor Acceptor
Consensus NAGgtaagt nttntnttttttttncagG
M33 (GCR) UL33 41518 41680 ATGgtaagc tcgccctctcgcccgcagG
M36 UL36 49036 48909 AAGgtgagt cgacgtcctccctaaaagG
M89 UL89 137393 132770 AACgtgagt cgtctcttcctcacgcagA
M112 (don) UL112 163889 AATgtaagt
M113 (aac) UL113 163983 gttactctgttcggaaagG
M113b UL113 164159 164486 ATGgtgcgt cttcctccgaattcacagG
m119 (don)c UL119 171684 ACAgtaagt
M118 (acc) UL118 171581 tgtctttctctcccacagC
m123 (ie1) UL123 (IE1)d
Exon 1 182596 AATgtaagt
Exon 2 181660 181766 CAAgtaagt ttatatttttttagagagA
Exon 3 181372 181562 CAGgtgagt ccactcttgttctctcagG
Exon 4 181249 accactcttatattccagT
M122 (ie3) UL122 (IE2) 179517 actctttatggttcacagG
Exon5 Exon5
m128 (ie2) Nil
Exon 1 184347 CGGgtaagg
Exon 2 185717 185594 CTAgtgagt ctctcttgttctccatagG
Exon 3 186083 ggttctgtttgtctgtagA
m132 Nil 188881 GCGgtacgt
188840e GTGgtacgt
m133 (sgg1) Nil 188601 cccgtttttgtctttcagG
a The locations of the last base of exon 1 and the first base of exon 2 (underlined) are shown for the prototype arrangement of the MCMV genome. When splicing
is between two ORFs, these ORFs are indicated as don or acc. Additional transcription data from references 70, 97, and 98.
b Transcription data from reference 17 describes an additional intron, resulting in a frameshift and a stop at position 164505 rather than 165076 as predicted here.
cMCMV m119 conserves position but not amino acid sequence with HCMV UL119.
dMCMV ie1 conserves position and function but not amino acid sequence with HCMV UL123(IE1).
e The second donor present in strain Smith (but not in the published strain K181 sequence [74]) would produce a larger ORF if spliced to the same acceptor.
TABLE 2—Continued
MCMV
gene
Length
(aa)
HCMV
homolog:
Homolog
length (aa)
FastA identity for
overlap (%)
Overlap
length (aa)
FastA
scoreb
M113 365 UL113 P 499
M112 Ex2 59 UL112 252 34 274 389
M112 Ex3 7 UL112 252 34 274 389
M114 262 UL114 (UNG) 250 52 262 725
M115 274 UL115 (gL) 306 32 228 384
M116 645 UL116 344 15 172 98
M118 217 UL118 209 21 196 106
M121 698 UL121 P 180 47 19 55
M122 Ex5 512 UL122 (IE2) 495 33 346 531
m128 Ex3 404 US22 (GF2) 593 20 173 135
m139 644 US22 (GF2) 593 30 357 472
m140 484 US23 (GF2) 592 29 410 611
m141 508 US24 (GF2) 500 29 400 538
m142 435 US26 (GF2) 603 28 276 376
m143 557 US23 (GF2) 592 27 372 411
a For FastA calculations, the length of overlap in amino acids, percent identity of the two proteins, and raw FastA scores for the alignments are shown. See Table
1, footnote a, for abbreviations and symbols.
b In some cases, comparison of MCMV with another herpesvirus or eukaryotic gene has produced a higher FastA score; this is discussed in the text.
c P, positional homology, but minimal sequence homology over short regions only, for the genes M23, M43, and M121.
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including uracil-DNA glycosylase (M114), ribonucleotide reduc-
tase (M45), and dUTPase (M72), are found in MCMV. The
ribonucleotide reductase homologs of both MCMV and HCMV
are smaller than the large subunit of the HSV enzyme (97 kDa
compared with 124 kDa for HSV), bothMCMV andHCMV lack
a homolog of the small subunit of the enzyme, and both may not
be functional as ribonucleotide reductases. In MCMV the
position analogous to the location of the small subunit is
occupied by M44, which is a homolog of the essential DNA
polymerase accessory protein of HCMV (45). The dUTPase
homolog in MCMV does not contain motifs usually found in
functional dUTPase enzymes (116).
As was found for HCMV, MCMV does not encode a thy-
midylate synthetase or a thymidine kinase gene. An MCMV
homolog (M97) of the herpesvirus phosphotransferases includ-
ing HCMV (UL97), HHV-6 (U69), HHV-7 (107a), and HSV
(UL13) was identified. This gene conserves the domain struc-
ture of eukaryotic protein kinases, and the strongest similarity
between the genes is in the carboxy-terminal region. In
HCMV, UL97 has been shown to phosphorylate GCV (82),
and MCMV has also been shown to be susceptible to this drug
in infection of mice (107). MCMV, like HCMV, does not
encode additional protein kinases, as are present in some al-
phaherpesviruses, such as HSV-1 US3 and CCV ORFs 73, 74,
14, 15, and 16 (37). HCMV is predicted to contain a putative
pyruvoyl decarboxylase gene (UL77). The prediction was
based upon the presence of a single pyruvoyl decarboxylase
enzyme prosthetic group (PDEPG) site, with the sequence
TLGSSLFN (156). MCMV encodes a strong homolog of UL77
(M77), with the sequence TLGQQFFN in the region of the
gene congruent with the potential PDEPG site. HHV-6 con-
tains a homolog of UL77 (U50), which is shorter by 73 residues
and does not contain a PDEPG site (51).
(iv) Regulatory genes. MCMV homologs of HCMV regula-
tory genes, whose products are important in the temporal
cascade of viral gene expression, include genes within the MIE
region (138), the UL36 to UL38 region (72), the TRS1-IRS1
genes (137), and UL69 (151). However, no homolog of the
differentially spliced HCMV US3 transcription unit was found
(26, 150). The organization, sequencing, and mapping of the 59
coterminal transcripts of the MCMV MIE gene locus have
been previously described (68). The MIE region of MCMV is
roughly colinear with that of HCMV, and matching splicing
patterns between HCMV IE1-IE2 and MCMV ie1-ie3 have
been characterized (68–70, 97). In both viruses transcription
from the MIE genes is controlled by a strong enhancer (42).
The spliced m128(ie2) gene of MCMV has been previously
sequenced and has sequence similarity to members of the
US22 family of HCMV (98) and MCMV. The sequence de-
termined here has an additional C nucleotide at position
187166, resulting in a frameshift at the carboxy terminus of
m128(ie2). The m128(ie2) gene is therefore predicted to en-
code a slightly longer peptide of 404 (rather than 391) amino
acids (Table 1).
MCMV (and HHV-6 [109]) do not encode homologs of
UL37 exons 1 and 2. HCMV TRS1-IRS1 are members of the
US22 gene family and encode a transactivator(s) of HCMV
UL44. m143 is the US22 gene family homolog that is most
similar to TRS1-IRS1 (Table 4). However, the level of amino
acid similarity between m143 and TRS1-IRS1 is considerably
lower than that between other US22 members, such as US23,
US22, US26, and US24. MCMV contains a homolog (M44) of
HCMV UL44 (Tables 1 and 2). HCMV UL44 is the putative
target gene that is transactivated by HCMV TRS1. MCMV
M44 has a distinctive motif repeated at nine locations through-
out the gene, that of a lysine followed by two charged residues.
Although similar motifs are observed in HCMV UL44 (45),
they are restricted to the carboxy terminus and are of uncertain
functional significance.
HCMV UL69 is a transactivator of early genes, and an
MCMV homolog (M69) was found. Homologs of these genes
have also been detected in the alpha- and gammaherpesvi-
ruses, where they have also been defined as trans-regulators of
gene expression (151). The MCMV homolog contains a signa-
ture sequence present in mitochondrial energy transfer pro-
teins (105), but this sequence is not present in HCMV UL69,
and it is very unlikely to be biologically significant. Like
HCMV UL69, MCMV M69 differs from the homologous
genes of other herpesvirus subgroups in having a unique car-
boxy-terminal amino acid sequence. MCMV ORFs M121 and
M116 were found to have sequences similar to the HSV-1 IE
transactivator ICP0 (Table 1). This similarity may result from
compositional bias, given the high content of serine, threonine,
and alanine residues in HSV-1 ICP0 and the MCMV proteins.
TABLE 4. Members of the gene families of MCMV and homologs of HCMV gene families
Index ORF of
gene family Members of gene family Characteristic motifs
HCMV
homolog(s) Reference(s)
m02 m02 m03 m04 m05 m06 m07 m08 m09
m10 m11 m12 m13 m14 m15 m16
NAXWXX E/H Wo, CXLXXC L/P
W/R o, CXXXXC, C(X)5CIXA
T/S, WrXXW, CXXXoC, oE M/R
Q (for m07 to m10 genes), CXX
T/I XC (for m11 to m16 genes)
Nil
M25 M25 M35 UL25 family 22
UL25, UL35
M33 M33, M78 G protein-coupled receptor motif
(M33 only), multiple transmem-
brane domains, S-T-rich carboxy
terminus
UL33 US27 21, 35, 51, 150
US28, UL78
M23 M23 M24 m25.1 m25.2 M36 M43
m128(ie2) m139 m140 m141 m142
m143
oCCXD/EX1–4oXXoG, two runs of
hydrophobic residues,
ooooDXXGXo, carboxy-terminal
acidic residues
US22 family 72, 150
M82 M82(pp71) M83(pp65) UL82 family 123
m145 m145 m146 m150 m151 m152 m153
m154 m155 m157 m158 m17
—a Nil
a See text.
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Comparison of M121 and HSV-1 ICP0 shows a FastA score of
209 and 20% amino acid identity over a 435-amino-acid over-
lap, with alignment beginning around position 230 in both
proteins and extending to the carboxy-terminus. MCMVM116
also has a FastA score of 215, with similar levels of homology,
but the alignment begins between M116 position 20 and ICP0
position 385.
(v) Structural proteins. MCMV encodes homologs of the
herpesvirus major capsid protein (M86), the large tegument
protein (M48), and a minor capsid protein (M46). Homologs
of the HSV-1 capsid components VP19C (HSV UL38), VP26
(HSV UL35), and the tegument protein Vmw65 (HSV UL48)
were not found in MCMV by using amino acid identity
searches. Found were homologs of genes encoding structural
proteins unique to the beta-herpesvirus group, which includes
the upper (M82) and lower (M83) matrix proteins as well as
the large (M32) and small (M99) phosphoproteins. The prod-
uct of the M99 gene has been shown to be around 16 kDa in
size and to be associated with the virion (31). The HCMV
UL80 assembly protein is presumed to function in packaging
DNA. A protease is encoded by the N-terminal region of UL80
that cleaves the assembly protein precursor at a site near the C
terminus. The MCMV homolog (M80) of the assembly protein
of HCMV (UL80) conserves the domain structure and cleav-
age sites present in HCMV UL80. MCMV is different in that
the conserved CD1 and CD2 domains are separated by 100
amino acids, whereas in all other sequenced herpesviruses the
two domains are separated by 80 to 84 residues (84). MCMV
M56 is homologous to HCMV UL56, HSV-1 UL28 (icp18.5),
and the processing proteins of equine herpesvirus 1 (EHV-1),
pseudorabies virus (PRV), EBV, and VZV (94). The 130-kDa
product of HCMV UL56 is associated with the nucleocapsid-
tegument fraction and has been shown to be nonglycosylated
(12). The gene product may be involved in capsid maturation,
by analogy with the HSV-1 gene product (94). The sequence
determined here for M56 differs from the published sequence
of strain Smith (99) by a single conservative change from an
alanine to a threonine at position 235.
(vi) MCMV glycoproteins with homologs in HCMV. A total
of 64 genes that could possibly encode glycoproteins were
identified by similarity to known herpesvirus glycoproteins or
by the presence of likely trans-membrane hydrophobic se-
quences and potential N-linked glycosylation sites (of the form
NXT/S, where X represents any amino acid) (93). Potential
MCMV glycoproteins include homologs of the conserved her-
pesvirus glycoproteins gB (M55), gH (M75), gM (M100), and
gL (M115). MCMV M115(gL) has significant amino acid sim-
ilarity to the gL homologs present in HCMV and HHV-6. No
homologs of the HCMV glycoproteins gpUL4(gp48), gpUS10,
gpUS11, or gpUL16 were found in MCMV (131). The amino
acid sequence of gB (M55) determined here differs from that
previously found for strain Smith by having 10 additional
amino acid residues and 22 amino acid transversions (44, 119).
The gH (M75) sequence found here has an additional amino
acid (C604) and 10 nonconservative and 22 conservative amino
acid substitutions, compared with the published sequence of
strain K181 (154).
Previous studies have established that gL from the alpha-,
beta-, and gammaherpesviruses associates with gH (67).
MCMV M115(gL) contains five potential glycosylation sites,
and it has previously been shown to be glycosylated in virions
(155). The MCMV gM homolog (M100) has seven hydropho-
bic stretches that are potential membrane-spanning regions,
and the hydropathicity plot resembles that of HCMV UL100.
The derived amino acid sequence contains four potential N-
linked glycosylation sites, two of which are congruent with the
sites present in HCMV. The MCMV homolog lacks the highly
acidic carboxy-terminal residues present in UL100 of HCMV.
Also, the MCMV M100 gene in strain Smith may have an
additional 24 residues at the amino terminus, as there is an
additional Kozak consensus methionine upstream of the ho-
mologous methionine found in HCMV. However, transcrip-
tion data in strain K181 suggest that the M100 gene does not
contain these additional 24 residues, as the mRNA start site is
at nucleotide 145373 or 145368, with the translation start at
145357 (79, 126).
The m138 gene has previously been described as encoding a
receptor for the Fc domain of murine immunoglobulin G mol-
ecules (142). The gene lies on the complementary strand, be-
tween nucleotides 192236 and 193942, with the mRNA start
site at 193998 (Table 1). A 1.9-kb transcript has been described
from 2 h postinfection, with maximal transcription between 8
and 24 h postinfection (142). The other membrane glycopro-
teins, which occur as gene families, are described below.
Families of homologous genes of MCMV. MCMV encodes
six groups of gene families. Two of these families are unique to
MCMV, and four have homologs in HCMV (Table 4).
(i) The US22 family.Members of the US22 gene family have
previously been found in HCMV (72, 150), HHV-6 (109), and
HHV-7 (107a). Twelve ORFs with homology to members of
the US22 family are present in MCMV. The homologs are
arranged in a similar fashion along the MCMV and the HCMV
genomes, as two clusters of tandemly repeated homologs at
either end of the genome, with additional single genes located
elsewhere. They are characterized by short stretches of hydro-
phobic and charged residues, as well as one or more conserved
sequence motifs (Table 4). Four sequence motifs have been
identified previously in the members of this family in HCMV,
and these four motifs as well as an additional motif were found
in the MCMV family members. The most strongly conserved
motif is ooCCXD/E(X)1–4oXXoG (where o represents any
hydrophobic amino acid and X represents any residue). This
motif occurs first in the predicted peptide sequence of all
members of the US22 gene family, with the exception of M43
and m128, and is only partially conserved in m25.1. This motif
has also been identified in members of the US22 family in
HCMV (72) and in HHV-6 (109). The acidic domain present
in the carboxy-terminal region is most prominent in M23,
m139, and m142.
The functions of the members of the US22 family in HCMV
and MCMV are unclear, although mutagenesis of at least two
members of the US22 family [m128(ie2) and m139] in MCMV
does not result in a phenotype different from the wild type
when it is grown in cell cultures (86, 146). In other beta-
herpesviruses some members of this family are transactivators
[HCMV TRS1-IRS1 participates in transactivation of HCMV
UL44(icp36) (137)], and HHV-6 EPLF3 is able to transacti-
vate the HIV-1 LTR (109). Multiple alignment of the 12 mem-
bers of the family in MCMV showed that ORFs m139 to m143
at the righthand side of the genome were more similar to each
other and to the colinear US22 to US26 members of HCMV
than to the US22 family members located at the lefthand side
of the MCMV genome. The converse was also true, in that
MCMV US22 members at the lefthand side of the genome
were found to be more similar to each other than to members
at the righthand side of the genome. In addition, an amino-
terminal motif (GXXoXoXWP) that is conserved in HCMV
UL23, UL24, and UL36 (exon 1) and in HHV-6 ORFs U2, U3,
U17, and U25 is present only in MCMV M24 and M36 (exon
1). The multiple alignments suggest that US22 members may
be subdivided to describe ORFs which are UL-like (i.e., similar
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to US22 members in the long unique region of HCMV) or
US-like (most similar to US22 to US26).
(ii) The MCMV m02 family of genes. The MCMV family
m02 contains 15 members. The members differ in length from
133 amino acids (m13) to 356 amino acids (m08). Hydropath-
icity plots (not shown) demonstrate the presence of a hydro-
phobic carboxy-terminal (anchor) sequence and a shorter ami-
no-terminal signal sequence in all members of the family. All
members of the m02 gene family lie in tandem on the top
strand at the left end of the prototype MCMV genome. They
all contain the sequence CXXXXC, contain potential N-linked
glycosylation sites (of the form NXT/S), and resemble each
other in global sequence alignments (with FastA scores of
more than 100 to other members of the m02 family but not to
other MCMV genes). Alignment of the 15 sequences demon-
strates that the genes cluster into three groups (m02 to m06,
m07 to m10, and m11 to m16) if conserved cysteine residues
are used as a primary criterion for alignment.
The m02, m03, m04, m05, and m06 genes all contain the
sequences CXLXXCL/PW/Ro and a proline-rich region in the
carboxy third of the gene. In addition, the m03, m04, m05, and
m06 genes all contain the sequence NAXWXXE/HWo toward
the start of the predicted protein sequence. The m07 to m10
genes all contain the motifs C(X)5CIXAT/SWrXXW (where r
is a charged or polar amino acid), CXXXoC, and oEM/RQ.
The m07, m08, and m09 sequences align more closely with
each other than with m10 and contain several other highly
conserved motifs that are not present in m10. The m11 to m16
genes vary in length more than the other two subgroups (Table
1), but all have similarly located cysteine residues and conserve
a CXXT/IXC motif.
(iii) The MCMV m145 family of genes. Members of the
m145 gene family are found on the complementary strand of
the prototype genome, arranged in tandem toward the right
end, except for m17, which lies at the other end of the genome
immediately at the end of the gene block containing the m02
gene family (Fig. 3). The genes vary in length from 329 to 487
amino acids, and all contain potential signal sequences, anchor
sequences, and potential N-linked glycosylation sites (Table 1).
None of the predicted genes are homologous to known her-
pesvirus proteins. The genes m145, m146, m150 to m154, and
m17 all conserve three cysteine residues located in the middle
third of the protein.
MCMV ORFs with homology to cellular genes. (i) MHC
class I homolog. The predicted protein encoded by m144 is
similar to class I MHC proteins. However, the MCMV MHC
class I homolog does not possess positional homology or sig-
nificant sequence similarity to the MHC class I homolog of
HCMV encoded by UL18 (FastA score of 61 for an overlap of
40 amino acids). MCMV m144 contains four potential N-
linked glycosylation sites (of the form NXT/S), which is similar
to the number of potential sites present in many MHC class I
molecules but many fewer than the 13 potential sites present in
HCMV UL18. Nevertheless, both MCMV m144 and HCMV
UL18 possess three extracellular regions that resemble the
MHC class I domains a1, a2, and a3, and putative leader,
transmembrane, and cytoplasmic sequences. The most strongly
conserved section is the a3 domain, which contains the beta-
2-microglobulin (b-2m) binding region in MHC class I mole-
cules. The predicted MCMVMHC homolog possesses cysteine
residues at three out of four sites that are conserved with MHC
class I proteins, including two cysteine residues within the
analogous a3 domain, which form internal disulfide bonds
flanking an evenly spaced globular domain. However, the
MCMV homolog is considerably shorter in the a2 domain than
in MHC class I proteins or HCMV UL18, which would affect
the conformation of the classical antigen-binding cleft. The
presumptive CD8 binding site (the motif RFDS) within the a1
domain of MHC class I proteins is not found in either m144 or
HCMV UL18 (123a).
(ii) GCR homologs. Homologs of the eukaryotic GCRs are
encoded by HCMV UL33, US27, and US28 (21) and possibly
UL78 (51). To date, UL33, US27, and US28 have been shown
to be transcribed (148). The MCMV GCR homolog (M33)
most closely resembles HCMV UL33 and is located in a co-
linear position. The two cysteine residues that are highly con-
served between members of the GCR family (and essential for
the structure of bovine rhodopsin [65]) are conserved in the
M33 protein (positions C118 and C201). Two additional cys-
teines located toward the carboxy terminus of the proteins are
conserved between M33, HCMVUL33, HCMVUS28, and the
human RDC1-like GCRs (80). The biological functions of the
HCMV GCR proteins are as yet unknown, and in vitro studies
of the MCMV GCR homologs will be of particular interest.
The MCMV M33 and HCMV UL33 genes have recently been
shown to undergo mRNA splicing near the amino end of the
protein (35). Recently the HHV-6 U51 gene has been de-
scribed as a GCR homolog, and the HCMV UL78 gene has
been predicted to be a member of the GCR family (51).
MCMV M78 is homologous to HCMV UL78, HCMV US28,
and HHV-6 U51 and to known GCRs. The M78 gene is more
closely related to the viral counterparts in HCMV (UL78) and
EBV than to the cellular GCRs. The opposite is true of the
HHV-6 U51 gene, which more closely resembles the cellular
GCRs than the viral homologs (51).
DISCUSSION
The two strains of MCMV studied in most detail are the less
virulent, laboratory-passaged Smith strain and the more viru-
lent K181 strain (57, 58), which have different phenotypes in an
infected animal. Genotypic differences between K181 and
Smith strains have not been extensively studied. We have
shown relatively minor differences between the DNA se-
quences and predicted amino acid sequences of the Smith and
published K181 genes m133(sgg1) (74), M55(gB) (44, 119),
and M75(gH) (154).
The complete DNA sequence of MCMV was checked
against databases containing the complete sequences of HSV-
1, VZV, HCMV, EHV-1, EBV, and CCV (2, 6, 22, 37, 38, 94,
141). Despite significant differences in the overall arrangement
of the genomes of MCMV and HCMV (103), we have dem-
onstrated that as previously predicted, the genomes are very
similar at the genetic and nucleotide compositional levels (55).
Indeed, plots of the G1C content of the genomes show simi-
larities when both 230-kb sequences are aligned. The G1C
content is reduced at the ends of the MCMV genome, regions
which are predicted to encode genes of the glycoprotein fam-
ilies m02 (left end) and m145 (right end). The left end of the
genome of HCMV AD169 has a low G1C content, but the
right end has a higher G1C content of around 56%. Both
MCMV and HCMV have a high G1C content immediately
adjacent to the right and left ends of the genome. As the
predicted coding regions of the genome have an overall higher
G1C content than the noncoding regions, the relationship
between the reduced G1C content in these regions and the
occurrence of these gene families is interesting. It is uncertain
whether the occurrence of these gene families results from
evolutionary pressures applied by the host immune response to
virally encoded proteins or from other causes (149). It is note-
worthy that abundant early transcripts are encoded by genes
near both termini (88), as these may feature in the viral charges
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to the host immune response. As expected, MCMV genes with
significant amino acid homology to HCMV genes are all lo-
cated in the central parts (around 78%) of both genomes.
Transcriptional data are available for differentially spliced
transcripts from ORFs M122, m123, and m128 within the
MCMV MIE region (42, 69, 70, 88, 97). By analogy with
HCMV, the MCMV MIE regions ie1, ie2, and ie3 (135) are
predicted to extend between positions 165599 (M114) (77, 120)
and 187296 [M128(ie2)]. The sequence around 700 bp up-
stream of the m123(ie1) gene (like the homologous region in
HCMV) contains a strong enhancer, made up (at least in part)
of five 94-bp tandem repeats (Fig. 2) containing many tran-
scriptional regulation sites (42).
This study and previous work (69) have shown MCMV en-
codes ORFs (MIE, M36-M38, and m143) similar to three of
the four regions of HCMV that are transcribed at IE times
(MIE, UL36-38, TRS1, and US3). MCMV does not contain a
homolog of the HCMV US3 ORF, which is nonessential for
growth in cell culture (71) and nonessential for growth in
SCID-hu mice (52). Unlike HCMV UL37, the MCMV M37
gene has no obvious second exon and no consensus splice
donor or acceptor sites (72). The arrangement of the UL37
homolog in this region of MCMV (and that of HHV-6 [109])
therefore differs from HCMV at the nucleotide sequence level.
MCMV m143 is similar to TRS1 (a member of the US22 gene
family). HCMV TRS1 is expressed at IE times and transacti-
vates the UL44(icp36) promoter (137). However, MCMV
m143 is more closely homologous to HCMV US22 and US23
than to TRS1 (Table 2), so whether M143 and TRS1 are
functionally related remains very uncertain.
MCMV homologs of other genes with regulatory functions
in HCMV and HSV include M121, M44(DPAP), and M69.
MCMV M121 has low-level sequence similarity and positional
homology with HCMV UL121 (Table 3), and it is located
immediately downstream of MCMV ie3 (M122). The M121
gene has low-to-moderate global similarity (19.8% identity
over a 435-residue overlap) with HSV ICP0 (IE110 or
Vmw110), possibly as a result of compositional bias rather than
genetic similarity (94). ICP0 has a role in virus switching from
latent to lytic infection and has been shown to transactivate
promoters from other herpesviruses, including HCMV (46).
The ICP0 protein contains a functional zinc finger sequence
close to the amino terminus (47, 145) and has a carboxy-
terminal region that allows heterocomplex formation (24).
MCMV M121 does not contain a consensus zinc finger motif
(11). Immediately before the carboxy terminus of M121 is a
short stretch of charged amino acids (RRTRSVY), and the
gene contains one highly charged region (of 10 acidic resi-
dues), which are features of some trans-acting transcriptional
activators (101).
MCMV encodes proteins with amino acid similarity to all of
the known enzyme homologs encoded by HCMV. To date,
M54(DNA polymerase) is the only MCMV enzyme for nucle-
otide metabolism to have been studied in any detail (44, 110).
Neither MCMV nor HCMV encodes a thymidine kinase, and
neither virus has been shown to enhance the activity of cellular
thymidine kinase (110). The HCMV UL97 protein kinase ho-
molog phosphorylates the nucleoside analog GCV in cell cul-
ture (82, 139), and MCMV is susceptible to GCV (124). MCMV
is more sensitive than HCMV to acyclovir, and this enhanced
susceptibility may reside in the DNA polymerase (M54), rather
than the phosphotransferase (M97), as mutants resistant to
acyclovir also show less susceptibility to chemicals that interact
with DNA polymerase such as phosphonoacetic acid (44).
Infection with HCMV and MCMV results in increased syn-
thesis of cellular polyamines (spermine and spermidine) in
cultured cells. These amine products are known to be incor-
porated into AD169 virions (25). Pyruvoyl decarboxylase en-
zymes form a PDEPG that is part of the active site of the
enzyme during synthesis of cellular polyamines (156). HCMV
UL77 is a pyruvoyl decarboxylase homolog and contains a
PDEPG (156). MCMV M77 has strong homology to HCMV
UL77, and M77 contains a single PDEPG site congruent with
that of HCMV. It will be of interest to investigate whether the
HCMV or MCMV pyruvoyl decarboxylase homolog can be
shown to be functional in polyamine biosynthesis, particularly
as inhibitors of ornithine decarboxylase (such as D,L-a-di-
fluoromethylornithine) that reduce polyamine biosynthesis
also reduce the number of HCMV particles released from
infected cells in cell culture (50).
HCMV has been predicted to encode at least 35 structural
proteins (22, 31, 131). MCMV homologs of the structural
genes present in pre-B capsids of HCMV are M86 (the major
capsid protein), M46 (a minor capsid protein), and M80; the
last is a homolog of the capsid assembly proteins of simian
cytomegalovirus and HCMV (UL80) (84, 122). It was not pos-
sible to determine if a homolog of the 12-kDa protein of
HCMV pre-B capsids was present, as the gene encoding this
has not yet been identified (131). HCMV UL80 encodes sev-
eral phosphoproteins. A protease of 28 kDa (UL80a) is tran-
scribed from the amino-terminal region. It cleaves the UL80
phosphoprotein to produce the final proteins (9, 18) in a fash-
ion similar to the protease of HSV-1 (UL26.5) (83). There is
considerable potential for the M80 gene to be used as a model
to study the characteristics of the assembly protease of HCMV
in the mouse system.
The MCMV genome contains sequence homologs of the
HCMV tegument proteins pUL32, pUL48, pUL82, pUL83,
and pUL99 but not pUL65 (131). The MCMV tegument pro-
tein homologs are predicted to be similar in length and mo-
lecular weight to the HCMV proteins, except for M32 and
M99, both of which are around half the predicted size of their
HCMV counterparts, pUL32 and ppUL99, respectively (131).
Recent studies have shown the M99 (pp16) gene product is
phosphorylated, is 15.2 or 16.3 kDa in size, is recognized by
mouse hyperimmune serum, and migrates in gels with appar-
ent molecular weights different from those predicted from the
primary amino acid sequence (31). The MCMV homolog
(M83) of the HCMV upper matrix protein is predicted to
encode a protein of 809 residues and a molecular mass of 90.9
kDa, which is around 50% larger than HCMV ppUL83(pp65)
(62). As no homolog of HCMV UL65 was found on primary
sequence analysis, it will be of interest to investigate whether
splicing occurs in the region between M57 and M69 (Table 1)
to produce a UL65 homolog. MCMV M57 (MDBP) and M69
are ORFs that are homologous with HCMV transactivators of
early genes, and they lie in an area of low G1C content (Fig.
1) that also contains the origin of lytic replication (92).
Extensive families of homologous genes are not a general
feature of herpesviruses, but they have been described for the
beta-herpesviruses HCMV, HHV-6, HHV-7 (107a), and now
MCMV. HCMV encodes nine gene families, with the six larg-
est clustered at each end of the genome (22). Examination of
the MCMV sequence has revealed homologs of the HCMV
gene families US22, UL25, and UL82 and the GCRs. Weak
homology with a member of the RL11 family (m11) most likely
results from compositional bias. No members of the HCMV
gene families US1, US2, US6, and US12 were found in
MCMV. The product of the HCMV US22 gene is a nuclear
protein (ICP22) which is expressed at early and late times (102,
113). No other members of the US22 gene family were iden-
tified in HCMV by the MAb used to identify the US22(ICP22)
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gene product (102). The US22 gene family member TRS1 acts
as a transactivator (137), but no functions have been assigned
to the other members of the family. The HHV-6 homologs of
the US22 family (U25, U17, and U16) have been shown to act
as transactivators in cotransfection assays (109). As the US22
gene family has not been identified in alpha- or gamma-her-
pesviruses, the function of these genes may relate to the bio-
logical characteristics of beta-herpesviruses, although it is un-
known why HCMV, MCMV, and HHV-6 have evolved
duplicated members. It is reasonable to assume that their func-
tion is important to beta-herpesvirus infection of the natural
host, given the conservation of large numbers of the gene
family in all three mammalian beta-herpesviruses.
The occurrence of two gene families unique to MCMV (m02
and m145) is particularly interesting, as they (plus the US22
gene family) occupy the region congruent with the short
unique and long terminal repeat of HCMV. A single member
(m17) of the righthand-end (m145) family occurs downstream
of the cluster of the lefthand-end (m02) family (Fig. 3). It has
been hypothesized that duplication produces the gene families
and that this may account for the larger size of beta-herpesvi-
ruses (150). It seems likely that these gene families were pro-
duced by duplication and that a subsequent recombination
event produced this movement of the m17 gene. This would
appear more likely if recombination followed divergence of
HCMV and MCMV, as the MHC class I homolog is located
just before the first member of the righthand-end family in
MCMV (m145) but at the opposite end of the genome in
HCMV (UL18). Further studies of these two families will be of
particular interest, as significant homology with other herpes-
viruses was found for only one member of the m145 family
(m154 and EHV-1 gX), and this is most likely a result of
compositional bias (141).
In light of the fact that the HCMV and MCMV MHC class
I genes do not share strongly similar amino acid sequences, it
is intriguing that the class I MHC gene is conserved in both
beta-herpesviruses. The nature of the cellular gene product
suggests that homologs in HCMV and MCMV may play a role
in subverting the host’s immune response during virus infec-
tion, particularly as both viruses have been shown to reduce
synthesis of MHC class I proteins (19). It has been demon-
strated that early gene expression results in a reduction in
IE antigen presentation, with retention of the MHC class I-
MCMV peptide complexes in the endoplasmic reticulum (41).
Furthermore, recent evidence has shown that the reduction in
MHC class I synthesis that follows MCMV infection is due at
least in part to a gene product from within HindIII E (143).
Unlike MCMV, the HCMV-induced MHC class I shutdown
has been associated with an increased turnover of the MHC
class I protein, rather than retention in the endoplasmic retic-
ulum-cis-Golgi apparatus. The downregulation of class I ex-
pression in HCMV-infected cells has been associated (at least
in part) with the product of HCMV US11 (63). Previous stud-
ies aimed at determining the function of the HCMV MHC
class I homolog have shown that when expressed in vaccinia
virus, the UL18 gene product can bind b-2m (15). However, in
the context of HCMV infection, it was later demonstrated that
the MHC class I homolog is not involved in sequestering cel-
lular b-2m and is not directly responsible for the downregula-
tion of MHC class I typically observed in infected cells (15). As
the recombinant HCMV lacking the UL18 gene is indistin-
guishable from wild-type HCMV in cell culture, it is probable
that it plays a role either in the interaction with the host’s
immune system or in the infection of particular cell types in
vivo (14). This may be also true for the MCMV m144, the
MHC class I homolog.
The MCMV M33 ORF is homologous with the GCRs,
which are cell surface receptors that are coupled to G proteins
and are activated by extracellular ligands or photons (13). The
G proteins act by transducing signals from these surface re-
ceptors to a small number of effector molecules (such as ad-
enylyl cyclase), which then act upon intracellular functions.
Homologs of the eukaryotic GCRs are encoded by the beta-
herpesviruses HCMV [UL33, US27, US28 [21], and possibly
UL78 [51]), HHV-6 (109), HHV-7 (107a), and the gamma-
herpesviruses HVS (108) and EHV-2 (140). The HCMV GCR
homologs have been shown to be transcribed (148), and the
M33 and the HCMV UL33 genes are spliced at the 59 end to
an upstream exon (35). The M33 protein most closely resem-
bles HCMV UL33 and is located in a colinear position. The
two cysteines that are highly conserved between members of
the GCR family (and essential for the structure of bovine
rhodopsin [65]) are conserved in M33. Two additional cys-
teines (located toward the carboxy terminus) are conserved
between M33, UL33, US28, and the human RDC1-like GCRs
(80). The HCMV GCR proteins are of unknown function,
although US28 is capable of acting as a chemokine receptor in
vitro (106). In vitro and in vivo studies of the MCMV GCR
homolog will be of particular interest.
The provision of a complete genomic sequence of another
beta-herpesvirus has allowed assessment of genes common to
this group of herpesviruses. Study of the MCMV genes impor-
tant in the pathogenesis of infection will provide further infor-
mation about the role of these genes in infection of the host
with this virus. Furthermore, the information gained from ex-
periments with MCMV in the natural host should provide
information about homologous genes in HCMV. As many of
the MCMV genes with homologs in HCMV and HHV-6 are
not found in the alpha- or gammaherpesviruses, MCMV
should continue to provide useful information about the role
of these genes in the betaherpesviruses.
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